[Adenosine deaminase activity in blood cells; influence of cytostatic therapy in patients with acute leukemia and with renal transplants (author's transl)]. 1979

J Zajaczkowski, and I Reubi, and P Joller, and M Fràter, and H J Plüss, and W H Hitzig, and U Zellweger

A causal relation between the enzyme, adenosine deaminase (ADA), and immune dysfunction is well known: patients with congenital inactivity of ADA invariably suffer of severe combined immunodeficiency. In contrast, we found in patients treated with immunosuppressive drugs increased ADA enzyme activity. Previous findings on ADA activity in acute leukemias are until now controversial. We found normal to increased ADA activity in children with acute lymphatic leukemia (ALL) and acute myeloid leukemia (AML) in remission as long as they were treated with cytostatic drugs. In the group of cured leukemics (in continuous remission after suspension of the therapeutic regimen) the ADA activities were normal. These findings do not exclude a heterogeneity within the leukemia group. They do not explain the signs of cellular immunodeficiencies well known in patients with acute leukemias.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D009700 Nucleoside Deaminases Catalyze the hydrolysis of nucleosides with the elimination of ammonia. Deaminases, Nucleoside
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females

Related Publications

J Zajaczkowski, and I Reubi, and P Joller, and M Fràter, and H J Plüss, and W H Hitzig, and U Zellweger
January 1981, Allergie und Immunologie,
J Zajaczkowski, and I Reubi, and P Joller, and M Fràter, and H J Plüss, and W H Hitzig, and U Zellweger
March 1982, Klinische Wochenschrift,
J Zajaczkowski, and I Reubi, and P Joller, and M Fràter, and H J Plüss, and W H Hitzig, and U Zellweger
January 1981, Folia haematologica (Leipzig, Germany : 1928),
J Zajaczkowski, and I Reubi, and P Joller, and M Fràter, and H J Plüss, and W H Hitzig, and U Zellweger
July 1982, [Rinsho ketsueki] The Japanese journal of clinical hematology,
J Zajaczkowski, and I Reubi, and P Joller, and M Fràter, and H J Plüss, and W H Hitzig, and U Zellweger
August 1977, Cancer,
J Zajaczkowski, and I Reubi, and P Joller, and M Fràter, and H J Plüss, and W H Hitzig, and U Zellweger
March 1976, British journal of cancer,
J Zajaczkowski, and I Reubi, and P Joller, and M Fràter, and H J Plüss, and W H Hitzig, and U Zellweger
July 1977, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
J Zajaczkowski, and I Reubi, and P Joller, and M Fràter, and H J Plüss, and W H Hitzig, and U Zellweger
May 1981, Rinsho byori. The Japanese journal of clinical pathology,
J Zajaczkowski, and I Reubi, and P Joller, and M Fràter, and H J Plüss, and W H Hitzig, and U Zellweger
January 1988, Eksperimental'naia onkologiia,
J Zajaczkowski, and I Reubi, and P Joller, and M Fràter, and H J Plüss, and W H Hitzig, and U Zellweger
May 1982, Anales espanoles de pediatria,
Copied contents to your clipboard!